-
Sector Analysis
Atopic Dermatitis: 68-Market Analysis and Drug Forecast to 2033
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Atopic Dermatitis disease market through 2033. GlobalData estimated that the atopic dermatitis market was $10.8 billion across the 68MM in 2023. By the end of the forecast period in 2033, sales across these markets will reach $26.2 billion, increasing at a compound annual growth rate (CAGR) of 9.3%. This strong growth will be fuelled by driven by the launch of seven late-stage pipeline agents in...
-
Analyst Opinions
Biocomputing: Market Trends and Innovations
Biocomputing is transitioning from a research-led concept into a deployable computing paradigm, where computation is executed through molecular and cellular processes rather than electronic circuits. The latest Innovation Radar: Biocomputing report examines how biology is being engineered as a programmable execution layer, capable of storing information, processing logic, and generating outputs directly within biological environments. At the core of this shift is a maturing biocomputing stack that integrates biological substrates with digital infrastructure. Computation is encoded in DNA, RNA, proteins,...
-
Sector Analysis
Retinitis Pigmentosa: Market View, Current and Future Competitive Landscape
This reports provides a data-driven overview of the current and future competitive landscape in Retinitis Pigmentosa Therapeutics. • In 2024 and 2029, China is anticipated to have the highest number of diagnosed prevalent cases of RP, representing a large portion of global cases. • Currently, the RP market is largely reliant on off-label and symptomatic approaches. • The RP pipeline holds 102 molecules, with no assets in the pre-registration stage, four assets in Phase III development, and another 21 in...
-
Product Insights
Clinical Trials: What to Expect in 2026 - A Preview of Trials Planned to Initiate and Estimated to Complete
Clinical Trials: What to Expect in 2026? Planned and completing trials by phase, geography, sponsor type, therapy area, and DCT adoption. Identify pipeline trends and benchmark competitors with GlobalData insights.
-
Sector Analysis
Crohn's Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032
Crohn’s Disease Drug Market Forecast and Competitive Intelligence Across the 8MM GlobalData’s Crohn’s Disease market report provides detailed analysis of the therapeutics landscape across the eight major markets (8MM), combining market forecasts, pipeline intelligence, competitive assessment, and treatment usage insights through 2032. The report highlights that Crohn’s Disease drug sales across the 8MM are expected to increase from $9.5 billion to $13.8 billion by 2032, reflecting a CAGR of 3.9%. Growth is supported by the approval and launch of eight...
-
Product Insights
Gastroesophageal (GE) Junction Carcinomas - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Gastroesophageal (GE) Junction Carcinomas - Global Clinical Trials Review, 2025" provides an overview of Gastroesophageal (GE) Junction Carcinomas Clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroesophageal (GE) Junction Carcinomas. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2025" provides an overview of Cutaneous Squamous Cell Carcinoma (cSCC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Squamous Cell Carcinoma (cSCC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2025" provides an overview of Borderline Personality Disorder (BPD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Borderline Personality Disorder (BPD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Phenylketonuria (PKU) - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Phenylketonuria (PKU) - Global Clinical Trials Review, 2025" provides an overview of Phenylketonuria (PKU) Clinical trials scenario. This report provides top line data relating to the clinical trials on Phenylketonuria (PKU). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Epidermolysis Bullosa - Global Clinical Trials Review, 2025
GlobalData's clinical trial report, “Epidermolysis Bullosa - Global Clinical Trials Review, 2025" provides an overview of Epidermolysis Bullosa Clinical trials scenario. This report provides top line data relating to the clinical trials on Epidermolysis Bullosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.